Floatz logo

FCH

Myeloma Multiple

University Hospital, BordeauxSmall moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Myeloma Multiple cohort.

Asset / SponsorPhaseRating
FLAVONE, 3,3',4',5,7-PENTAHYDROXY-
Centro de Atencion e Investigacion Medica
Phase 4BBB
Eloxatin
OHSU Knight Cancer Institute
Phase 1/2CCC

Same molecule, other indications

FCH is also rated in:

breast carcinomaDormant
BB
Indicative ·
65 / 100
View asset →
Positron Emission TomographyDormant
BB
Indicative ·
65 / 100
View asset →
Magnetic Resonance ImagingDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →